Tom Wilemon

September 18, 2019

Jackson named to new VICC advanced practice role

Heather Jackson, MSN, RN, APRN, has been promoted to administrative director of Advanced Practice for Vanderbilt-Ingram Cancer Center.

By Tom Wilemon
DNA sequence
September 5, 2019

Study backs genetic testing for all metastatic breast cancer patients

By Tom Wilemon
September 4, 2019

Fashion event to help support ovarian cancer research

Vanderbilt Health physicians will be among the runway models during the 7th Annual T.J. Martell Foundation Chic Awearness on Sept. 23.

By Tom Wilemon
August 26, 2019

Colorectal cancer researchers receive SPORE funding

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

By Tom Wilemon
August 22, 2019

Grant strengthens breast cancer research efforts

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

By Tom Wilemon
August 15, 2019

Potential second-line melanoma treatment identified

A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.

By Tom Wilemon
August 15, 2019

Protein’s role in inflammation-related cancer studied

Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer.
By Tom Wilemon
August 7, 2019

Colorectal cancer patients warn against dismissing early symptoms

Younger patients say colorectal cancer is a disease that doesn’t follow age guidelines, so pay attention to early symptoms.
By Tom Wilemon
August 1, 2019

Shu, Zheng receive Vietnam’s top honor for foreign scientists

The Vietnamese Ministry of Health has awarded two Vanderbilt epidemiologists the Memorabilia Medal “For the People’s Health” in appreciation for their contributions in helping the nation establish a population-based research program for cancer, diabetes and other non-communicable diseases.
By Tom Wilemon
August 1, 2019

Grant bolsters research on myelodysplastic syndromes

Michael Savona, MD, has received a competitive grant to develop therapies for patients with myelodysplastic syndromes.
By Tom Wilemon
July 22, 2019

Encephalitis identified as rare toxicity of immunotherapy treatment

Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.
By Tom Wilemon
July 18, 2019

Center for Immunobiology grows, bolsters program

The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.
By Tom Wilemon